4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-24-007865
PRESIDENT AND CEO gave up 4,646 shares (to pay taxes)
- PRESIDENT AND CEO acquired 15,708 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin PRESIDENT AND CEO | 2024-03-11 | Option exercise | +15,708 | 5,308,557 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2024-03-11 | Shares withheld for taxes | −4,646 | $7.22 | $33,544 | 5,303,911 | D |
| Derivatives | |||||||
| Jiang Wenbin PRESIDENT AND CEO | 2024-03-11 | Option exercise · Restricted Stock Units | −15,708 | 141,377 | D | ||
Loading xslF345X05/form4-03132024_100343.xml…